The laboratory and the direct oral anticoagulants
- PMID: 23564912
- DOI: 10.1182/blood-2012-12-453076
The laboratory and the direct oral anticoagulants
Abstract
Although direct oral anticoagulants do not need laboratory testing for dose adjustment, there are instances when laboratory measurement of the drug anticoagulant effect may be useful. They include before initiation of treatment, before surgical or invasive procedures, on the occasion of hemorrhagic or thrombotic events, and whenever immediate reversal of anticoagulation is needed. Choice of tests should be primarily based on their prompt availability. Accordingly, the dilute-thrombin or the ecarin clotting times are best suited for dabigatran and the prothrombin time or the anti-FXa for rivaroxaban.
Similar articles
-
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.Br J Haematol. 2012 Nov;159(4):427-9. doi: 10.1111/bjh.12052. Epub 2012 Sep 13. Br J Haematol. 2012. PMID: 22970737 No abstract available.
-
The laboratory and the new oral anticoagulants.Clin Chem. 2013 Feb;59(2):353-62. doi: 10.1373/clinchem.2012.189704. Epub 2012 Oct 5. Clin Chem. 2013. PMID: 23043068 Review.
-
Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.J Thromb Haemost. 2014 Nov;12(11):1850-60. doi: 10.1111/jth.12726. Epub 2014 Oct 16. J Thromb Haemost. 2014. PMID: 25211369 Clinical Trial.
-
Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.Thromb Res. 2013 Aug;132(2):e161-3. doi: 10.1016/j.thromres.2013.07.011. Epub 2013 Jul 31. Thromb Res. 2013. PMID: 23916381 Free PMC article. No abstract available.
-
Bleeding and antidotes in new oral anticoagulants.Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21. Best Pract Res Clin Haematol. 2013. PMID: 23953907 Review.
Cited by
-
Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits.Open Life Sci. 2022 Jan 28;17(1):1-9. doi: 10.1515/biol-2022-0002. eCollection 2022. Open Life Sci. 2022. PMID: 35128064 Free PMC article.
-
Acute Stroke and Atrial Fibrillation: Risk of Incorrect NOAC Dosage When Estimating Renal Function From Plasma Creatinine Only.Front Neurol. 2022 Jul 5;13:907912. doi: 10.3389/fneur.2022.907912. eCollection 2022. Front Neurol. 2022. PMID: 35865641 Free PMC article.
-
Italian intersociety consensus on DOAC use in internal medicine.Intern Emerg Med. 2017 Apr;12(3):387-406. doi: 10.1007/s11739-017-1628-6. Epub 2017 Feb 13. Intern Emerg Med. 2017. PMID: 28191610
-
Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.J Am Coll Cardiol. 2014 Sep 16;64(11):1128-39. doi: 10.1016/j.jacc.2014.05.065. J Am Coll Cardiol. 2014. PMID: 25212648 Free PMC article. Review.
-
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry.Thromb Haemost. 2022 Apr;122(4):552-559. doi: 10.1055/a-1549-6556. Epub 2021 Sep 29. Thromb Haemost. 2022. PMID: 34256392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical